Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN110540516B reveals a mild visible-light mediated synthesis for dihydronaphthalene derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113980044B reveals a novel Ir-O-P catalyzed diboration method. This breakthrough enables cost-effective, scalable production of high-purity organoboron intermediates for drug discovery.
Patent CN105669546A enables efficient photocatalytic synthesis. Delivers high-purity fluorinated building blocks with significant supply chain and cost advantages for global pharmaceutical manufacturing.
Novel Rhodium-catalyzed oxidative coupling method enhances purity and reduces waste in API manufacturing, offering a reliable supply chain solution.
Patent CN110305054B details a green FeBr3-catalyzed route for N-(1-phenyl-2-(phenylseleno)ethyl)aniline derivatives, offering cost reduction and scalable manufacturing.
Novel one-pot synthesis of 2-alkyl quinolines using montmorillonite and iodine. High yield, low toxicity, scalable pharmaceutical intermediate manufacturing.
Patent CN113651788B enables green visible light catalysis for chromones. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN108558882B reveals a novel [3+2] cycloaddition route for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN113307778A reveals a mild Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering reliable pharmaceutical intermediate supply and cost reduction.
Novel synthesis method offers mild conditions and high yield for pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global partners seeking advanced antitumor solutions
Patent CN113549062A discloses bulky chiral quaternary ammonium salts enhancing enantioselectivity in KMnO4 oxidation, offering cost-effective API intermediate solutions.
Novel synthesis method for chiral indolo compounds with high enantioselectivity. Cost-effective manufacturing for pharmaceutical applications ensuring supply chain reliability.
Patent CN120923511A details mild synthesis of chiral vinyl indolo compounds. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103467354B reveals mild titanocene catalysis for bis-indolyl methane. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Novel copper complex enables room temperature synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101481369A reveals a metal-free NHC catalytic route for 4,6-substituted 3,4-dihydro-pyran-2-ones, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Discover novel axial chiral oxindole-derived styrene phosphine catalysts from patent CN111777637B. Enables asymmetric cyclization with mild conditions and scalable synthesis for fine chemical manufacturing.
Patent CN105481867A details a novel three-step relay catalysis method for high-purity chiral spiro-oxindole synthesis, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand offering superior stereoselectivity for asymmetric allylation and cost-effective pharmaceutical intermediate manufacturing.